HAEMOCTIN

This brand name is authorized in Austria, Spain, Hong Kong, Lithuania, Malta, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug HAEMOCTIN contains one active pharmaceutical ingredient (API):

1 Coagulation factor VIII UNII 5T6B772R4Q - HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX

Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies. Read about Coagulation factor VIII

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HAEMOCTIN Powder and solvent for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70008, 70009
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 327530, 327532, 327534
Country: HK	Department of Health Drug Office	Identifier(s): 60576, 60577, 60578
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007538, 1009886, 1009887
Country: MT	Medicines Authority	Identifier(s): MA008/00101, MA008/00102, MA008/00103
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100241120, 100241137, 100245626
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56023001, W56024001, W56025001
Country: SG	Health Sciences Authority	Identifier(s): 10411P, 14059P, 15337P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8153061H, 8153062H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8682109319829